ALPS Advisors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-103,482
| Closed | -$2.82M | – | 981 |
|
|
2018
Q3 | $2.82M | Buy |
103,482
+19,414
| +23% | +$530K | 0.02% | 210 |
|
|
2018
Q2 | $2.26M | Buy |
84,068
+8,168
| +11% | +$220K | 0.01% | 220 |
|
|
2018
Q1 | $2.42M | Buy |
75,900
+19,538
| +35% | +$622K | 0.02% | 196 |
|
|
2017
Q4 | $2.13M | Buy |
56,362
+6,594
| +13% | +$249K | 0.01% | 192 |
|
|
2017
Q3 | $1.23M | Buy |
49,768
+4,412
| +10% | +$109K | 0.01% | 223 |
|
|
2017
Q2 | $933K | Buy |
45,356
+2,302
| +5% | +$47.4K | 0.01% | 232 |
|
|
2017
Q1 | $936K | Buy |
43,054
+2,324
| +6% | +$50.5K | 0.01% | 222 |
|
|
2016
Q4 | $833K | Sell |
40,730
-13,137
| -24% | -$269K | 0.01% | 232 |
|
|
2016
Q3 | $808K | Sell |
53,867
-5,484
| -9% | -$82.3K | 0.01% | 230 |
|
|
2016
Q2 | $642K | Buy |
59,351
+11,837
| +25% | +$128K | 0.01% | 224 |
|
|
2016
Q1 | $644K | Sell |
47,514
-8,143
| -15% | -$110K | 0.01% | 204 |
|
|
2015
Q4 | $1.03M | Buy |
+55,657
| New | +$1.03M | 0.01% | 216 |
|